Application of hybrid reality technology (MR) in individualized surgical scheme selection of patients with liver cirrhosis and portal hypertension

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055799

Enrollment

Unknown

Registered

2022-01-20

Start date

2022-01-20

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis and Portal Hypertension

Interventions

Gold Standard:Hepatic Venous Pressure Gradient, HVPG

Index test:Non-invasive Hepatic Venous Pressure Gradient, Non-invasive HVPG

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years, 80 inclusive; 2. Patients diagnosed with cirrhotic portal hypertension; 3. HVPG measurement is successful and relevant data is available.

Exclusion criteria

Exclusion criteria: 1. Patients who are pregnant or breastfeeding; 2. Patients with serious abnormalities in coagulation, cardiac function, pulmonary function, or poor general condition; 3. Patients with thrombosis in hepatic vein, portal vein, and mesenteric vein; 4. Patients with hepatic malignancy or decompensated liver function (Child C or MELD > 25); 5. Patients with iodine allergy.

Design outcomes

Primary

Measure	Time frame
HVPG;Non-invasive HVPG;	—

Secondary

Measure	Time frame
Intraoperative blood loss;Operative duration;Postoperative complications;	—

Countries

China

Contacts

Public ContactHuo Haizhong

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine

fireseah@163.com+86 13917254400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026